. 2021 Mar 4;44(10):2273–2284. doi: 10.1007/s40618-021-01534-3

Table 2.

Mean ± SD, median (in brackets), 25th to 75th percentile distribution in italics and significance of the hormone levels in the two study groups (Mann–Whitney U test)

	FSH (mUI/ml)	LH (mUI/ml)	Testosterone (nmol/ml)
Group T	10.4 ± 7.2 (8.4) 6.2–12.3	5.5 ± 4.2 (4.5) 3.3–6.7	17.7 ± 6.4 (17.0) 13.3–21.4
Group C	4.1 ± 3.6 (3.1) 2.2–5.2	3.8 ± 1.7 (3.4) 2.6–4.8	21.6 ± 6.5 (20.7) 17.7–25.5
P value	< 0.001	< 0.001	< 0.001

FSH (mUI/ml)

LH (mUI/ml)

Testosterone (nmol/ml)

Group T

10.4 ± 7.2

(8.4)

6.2–12.3

5.5 ± 4.2

(4.5)

3.3–6.7

17.7 ± 6.4

(17.0)

13.3–21.4

Group C

4.1 ± 3.6

(3.1)

2.2–5.2

3.8 ± 1.7

(3.4)

2.6–4.8

21.6 ± 6.5

(20.7)

17.7–25.5

P value

< 0.001

Group T, patients with testicular germ cell tumours; Group C, cancer-free controls; FSH, follicle-stimulating hormone; LH, luteinizing hormone

Significant P values are in bold